NASDAQ:AFJK Aimei Health Technology (AFJK) Stock Price, News & Analysis $33.94 -8.06 (-19.19%) Closing price 03:58 PM EasternExtended Trading$35.25 +1.31 (+3.86%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Aimei Health Technology Stock (NASDAQ:AFJK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AFJK alerts:Sign Up Key Stats Today's Range$40.00▼$41.5650-Day Range$23.95▼$67.8652-Week Range$6.75▼$130.37Volume1,936 shsAverage Volume21,316 shsMarket Capitalization$107.59 millionP/E Ratio188.56Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York. Read More Aimei Health Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreAFJK MarketRank™: Aimei Health Technology scored higher than 17% of companies evaluated by MarketBeat, and ranked 81st out of 110 stocks in the financial services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingAimei Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAimei Health Technology has only been the subject of 1 research reports in the past 90 days.Read more about Aimei Health Technology's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aimei Health Technology is 233.83, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.31.Price to Earnings Ratio vs. SectorThe P/E ratio of Aimei Health Technology is 233.83, which means that it is trading at a more expensive P/E ratio than the Financial Services sector average P/E ratio of about 16.12. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.09% of the float of Aimei Health Technology has been sold short.Short Interest Ratio / Days to CoverAimei Health Technology has a short interest ratio ("days to cover") of 1.34, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aimei Health Technology has recently decreased by 52.34%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAimei Health Technology does not currently pay a dividend.Dividend GrowthAimei Health Technology does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment1.43 News SentimentAimei Health Technology has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Financial Services companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aimei Health Technology this week, compared to 3 articles on an average week. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aimei Health Technology insiders have not sold or bought any company stock.Percentage Held by Insiders2.50% of the stock of Aimei Health Technology is held by insiders.Percentage Held by Institutions45.58% of the stock of Aimei Health Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aimei Health Technology's insider trading history. Receive AFJK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aimei Health Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFJK Stock News HeadlinesAimei Health Technology (NASDAQ:AFJK) Trading Down 3.7% - Here's WhyMay 22, 2026 | americanbankingnews.comAIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORTMay 20, 2026 | globenewswire.comThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.June 1 at 1:00 AM | American Alternative (Ad)Aimei Health Extends SPAC Deadline, Issues New NoteMay 18, 2026 | theglobeandmail.comAIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORTApril 21, 2026 | globenewswire.comLatest Aimei Health Technology Stock News | NASDAQ:AFJK | BenzingaApril 9, 2026 | benzinga.comAimei Health Technology Co., LtdApril 9, 2026 | edition.cnn.comAimei Health Technology Delays Annual 10-K FilingApril 3, 2026 | theglobeandmail.comSee More Headlines AFJK Stock Analysis - Frequently Asked Questions How have AFJK shares performed this year? Aimei Health Technology's stock was trading at $64.01 at the beginning of the year. Since then, AFJK stock has decreased by 34.2% and is now trading at $42.09. How were Aimei Health Technology's earnings last quarter? Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) announced its quarterly earnings results on Monday, May, 4th. The company reported $0.02 earnings per share for the quarter. How do I buy shares of Aimei Health Technology? Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aimei Health Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aimei Health Technology investors own include Andretti Acquisition Corp. II (POLEU), Arogo Capital Acquisition (AOGO), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR) and Aimfinity Investment Corp. I (AIMAU). Company Calendar Last Earnings5/04/2026Today6/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5d) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 As of 5 days ago, AFJK's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry UNCLASSIFIED Sub-IndustryTrading Current SymbolNASDAQ:AFJK Previous SymbolNASDAQ:AFJK CIK1979005 WebN/A Phone34-67-803-5200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.18 Trailing P/E Ratio188.56 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.06 million Net MarginsN/A Pretax MarginN/A Return on Equity-33.32% Return on Assets2.91% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.40 per share Price / Cash Flow84.24 Book Value($1.91) per share Price / Book-17.77Miscellaneous Outstanding Shares3,170,000Free Float3,087,000Market Cap$107.59 million OptionableN/A Beta0.23 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NASDAQ:AFJK) was last updated on 6/1/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.